Mergers News
Monday, September 12, 2016
GSK sells anaesthetics to Aspen for up to $370 mln
LONDON, Sept 12 (Reuters) - GlaxoSmithKline is to
sell its portfolio of anaesthetic drugs to South Africa's Aspen
Pharmacare for up to 280 million pounds ($372 million)
as part of a drive by the...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment